Savara (SVRA) Asset Utilization Ratio (2013 - 2022)

Savara's (SVRA) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2022, down 99.59% on a QoQ basis from 0.0 in Q4 2021.

Savara (SVRA) Asset Utilization Ratio (2013 - 2022) Analysis & Trends

Savara (SVRA) has 8 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2022.

On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q1 2022; TTM through Mar 2022 was 0.0, a N/A change from a year earlier, with the FY2020 full-year figure at 0.0, changed N/A from the prior year.
Asset Utilization Ratio for Q1 2022 stood at 0.0, down from 0.0 in the prior quarter.
Over the last five years, Asset Utilization Ratio for SVRA reached as high as 0.0 in Q4 2020 and fell as low as 0.0 in Q1 2022.
Historically, Asset Utilization Ratio has averaged 0.0 across 3 years, with a median of 0.0 in 2021.
On a YoY basis, Asset Utilization Ratio climbed as much as 7.19% in 2021 and fell as far as 43.09% in 2021.
Year by year, Asset Utilization Ratio stood at 0.0 in 2020, then tumbled by 43.09% to 0.0 in 2021, then plunged by 99.59% to 0.0 in 2022.
Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q1 2022, 0.0 in Q4 2021, and 0.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.69
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.37
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Savara	1.24 Bn	1.24 Bn	-	-

Download Data